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Summary The effect of acute carbon monoxide (CO) breathing on blood oxygenation and tumour hypoxia
was related to the radiation response of the C3H/Tif mammary carcinoma. Blood gas analysis showed that
CO breathing caused a time- and dose-dependent formation ofcarboxyhaemoglobin (HbCO), a significant left
shift of the oxygen dissociation curve and a reduction in tumour blood perfusion. These factors all contributed
to a marked drop in tumour oxygen supply. In agreement with this, tumour hypoxia was found to be
significantly increased: Microelectrode P02 measurements showed a clear relationship between CO concentra-
tion and the proportion of low Po2 measurements (< 5 mmHg). The fraction of clonogenic hypoxic cells
increased from 8% in air-breathing animals to 13%, 18% and 54% with 75,220 and 660 p.p.m. CO
respectively. The tumour hypoxia resulted in significant radiation modification. The local tumour control after
single-dose and fractionated irradiation gave TCD50 enhancement ratios (relative to air-breathing controls) of
0.90, 0.85 and 0.89 for single dose and five or ten fractions given in 5 days (P<0.005 for all values). For 15
fractions in 5 days with 6- 6- and 12 h intervals, the TCD50 was similar in CO- and air-breathing mice,
presumably as a consequence of insufficient reoxygenation during the short inter-fraction intervals. It is
concluded that elevated HbCO levels lead to increased tumour hypoxia and that the induced hypoxia has a
significant impact on the local tumour control also after fractionated irradiation.
The presence of hypoxic cells in solid tumours is well
documented (Moulder & Rockwell, 1984; Gatenby et al.,
1988; Overgaard, 1989; Vaupel et al., 1991; Horsman, 1993;
Okunieff et al., 1993), and tumour hypoxia is believed to be a
major cause of clinical radioresistance in head and neck
cancer and certain other cancer types (Dische, 1989; Over-
gaard, 1989; 1993). The amount of oxygen available for a
given tissue depends on both the blood flow and the blood
oxygenation (Hirst, 1986). The latter parameter is potentially
influenced by several factors: inspired air characteristics
(smoke/pollution), cardiopulmonary status, haemoglobin
(Hb) amount and 'quality' and Hb-oxygen affinity (Over-
gaard, 1988). Apart from the registration of Hb level, details
about these parameters are usually not available in clinical
radiotherapy studies. A study including 115 head and neck
cancer patients has recently shown that the total Hb concen-
tration is a very crude indicator of the amount of oxygen
available for tissues. Instead the concept of 'oxygen
unloading capacity' has been introduced as a potentially
more reliable prognostic factor (Overgaard, 1988; Overgaard
et al., 1992).
Tumour oxygenation is theoretically influenced by the
presence of carboxyhemoglobin (HbCO), which is formed
when CO binds to Hb. Even low concentrations of CO can
lead to a significant level of HbCO in the blood, as the
affinity of Hb for CO is about 230 times that for oxygen
(Roughton & Darling, 1944). The major source of CO in the
inspired air is cigarette smoke (Nordenberg et al., 1990).
Many patients treated with radiotherapy, especially those
with head and neck cancer, are cigarette smokers (Des
Rochers et al., 1992; Overgaard et al., 1992), and they have
been found to have HbCO levels as high as 18% compared
with 1-2% in non-smokers (Bunn & Forget, 1986;
Nordenberg et al., 1990; Overgaard et al., 1992).
Previous animal studies have suggested that increased
HbCO may reduce the tumour response to single-dose
irradiation (Siemann et al., 1978; Grau et al., 1992). The aim
of the present experiments was to study the relationship
between blood/tumour oxygenation and tumour radiation
response during CO breathing. Blood oxygenation was
evaluated from blood gas analysis (HbCO, Hb, P5m), tumour
perfusion from 86RbCl experiments, and the effect on tumour
oxygenation was measured directly by P02 microelectrode
and indirectly by radiobiological hypoxic fraction estimation.
Material and methods
Mice and tumours
The C3H mouse mammary carcinoma was grown in the feet
of 10- to 14-week-old CDFI/Bom (C3H/tif Y x DBA/2 c)
male mice. The derivation and maintenance of the tumour
system has been described in detail previously (Overgaard,
1980; Grau & Overgaard, 1988). Tumours were treated when
they reached a volume of 200mm3, as determined by the
formula ic/6 x DI x D2 x D3, where the Ds represent the three
orthogonal diameters. All experiments were performed on
restrained non-anaesthetised animals.
Treatments and experimental techniques
Gassing Specific levels of HbCO were obtained by
incubating the mice in CO gas mixtures (75, 220 or 660
p.p.m. CO, ± 5%). The gases were produced and delivered
by Danish Oxygen and Hydrogen Ltd. Incubation was done
in a box flushed with CO at a flow rate of 5 1 min-'. The CO
incubation was maintained during irradiation by moving the
incubated mice to the radiation water bath, which was
covered with an airtight lid and similarly flushed with CO.
The HbCO levels in the treated mice were validated with
blood samples on a daily basis in conjunction with each
treatment session. A similar set-up was used for 86RbCl
measurements. Microelectrode P02 measurements were done
with the mice placed in a plastic jig, which was flushed with
CO at a flow rate of 1.25 1 min-' per jig. This flow rate was
found to result in HbCO levels identical to those obtained
with the incubation chamber.
Ventilation rate The ventilatory response to CO breathing
was studied using a mouse whole-body plethysmograph (von
der Maase et al., 1986). The mice were placed in a 132-cm3
chamber through which a constant air flow (atmospheric air
or CO) was passed, and the breathing rate recorded in Hz by
a built-in microphone. Results were calculated as means and
s.e. of six animals in each group.
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Blood sampling Venous blood samples (100-150pl) were
collected from the suborbital sinus and analysed for
HbCO%, pH, P02, Pco2, oxygen saturation and total Hb%
on an Acid Base Laboratory ABL300 (Radiometer, Copen-
hagen) connected to an OSM3 haemoximeter (Radiometer,
Copenhagen) calibrated for mouse blood. The Pso was cal-
culated automatically from these values (Siggaard-Andersen et
al., 1988). This value is defined as the oxygen partial pressure
at which Hb is 50% saturated with oxygen at normal pH,
and it thus describes the position of the Hb-oxygen dissocia-
tion curve. A fraction of the blood samples was analysed for
the content of 2,3-diphosphoglycerate (2,3-DPG). This was
done by a commercial kit (Sigma, St Louis, MO, USA). In
brief, the breakdown of 2,3-DPG to glyceraldehyde 3-
phosphate requires simultaneous formation of NAD, which
can be quantitated spectrophotometrically. The test was done
on protein-free supernatant, and the values calculated either
as whole-blood concentration (mmolI 1) or as a percentage
of the haemoglobin content, the latter parameter calculated
by dividing the whole-blood 2,3-DPG by the Hb content.
Intratumoral P02 measurement The intratumoral oxygen
tension was measured using a fine-needle polarographic elect-
rode (Eppendorf, Hamburg, Germany), as described
previously (Horsman et al., 1993). In brief, P02
measurements were conducted with mice restrained in lucite
jigs with the tumour-bearing foot exposed and loosely taped
in such a way that the normal blood supply was not
impaired. The needle was inserted up to a depth of 1 mm
into the tumour, and automatically moved through the
tumour in forward steps of 0.7 mm followed by a rapid
retraction of 0.3 mm. Three to six electrode tracks were used
in each tumour, yielding a total of 45-90 measurements per
tumour. The relative frequency of the Po2 was automatically
calculated and displayed as a histogram. For the present
purpose, the data were expressed as the percentage of
measurements with a P02 value less than or equal to
5 mmHg.
Tumour blood perfusion measurement Tumour blood per-
fusion was measured by the 86RbCl extraction technique
(Sapirstein, 1958). The practical application of this technique
in our set-up has been described in detail previously (Hors-
man et al., 1989; Grau et al., 1992). Briefly, a volume of
0.1 ml of 86RbCl was injected intravenously into each mouse.
After 2 min the mice were sacrificed and the tumour-bearing
leg was clamped. Tumours were excised for counting
immediately after sacrifice. Determinations of radioactivity
were made on a gamma-counter, and the radioactive counts
were expressed as percentage injected per g of tumour.
Irradiation Local irradiation was given with 250-kV X-rays
(2.3 Gy min-', 3.1 mm Cu HVL, 10mA) to mice with the
tumour-bearing foot immersed in a water bath (25°C) to
secure homogeneous dose distribution. Fractionated irradia-
tion was given with an interval between multiple daily frac-
tions of 6 h, and an overall treatment time of 4-4+ days.
Animals receiving X-rays under hypoxic conditions had the
tumour-bearing leg clamped 5 min before and during the
period of irradiation. Clamping was achieved by constriction
of the blood flow using a rubber tube tightened around the
leg (Grau et al., 1992).
End-points and statistics
Local tumour control assay The effect of graded doses of
radiation was evaluated as the dose required to produce local
tumour control in 50% of the treated animals (TCD50).
Tumour control was defined as complete absence of macro-
scopic relapse within 90 days. Each single experiment
included 6-9 dose points each with 6-12 mice. Less than
5% of the animals were censored as a result of death,
amputation or distant metastases. Data were analysed by
logit analysis (Grau & Overgaard, 1988). The enhancement
ratio (ER) was calculated as the ratio of TCD50 values
obtained under normal air-breathing and CO-breathing con-
ditions. An ER significantly lower than 1 thus reflected radia-
tion protection.
Hypoxic fraction The proportion of radiobiologically
hypoxic cells (HF) was estimated from the tumour control
data obtained for mice breathing CO at 0, 75, 220, or
660 p.p.m. together with data for the clamped tumours. One-
step direct estimation was performed using a modification of
the 'cxpest' computer program, with fixed a- and P-values of
0.53 Gy-1 and 0.087 Gy 2 respectively (Bentzen & Grau,
1991).
Statistical methods The experimental data were calculated
as means and 95% confidence limits using normal distribu-
tion unless otherwise stated in the text. Student's t-test with a
significance level of 5% was used in all analyses. Univariate
linear regression analysis (SPSS/PC + V4.01) was used to test
for correlation. The estimation of HF from tumour control
data and its confidence intervals were calculated from the
'cpest' computer program, as described by Bentzen & Grau
(1991).
Results
Breathing rate
Figure 1 shows the ventilation rate in CO- and air-breathing
mice. The initial breathing rate was about 270min-', but
when the mice became accustomed to the chamber this value
dropped to about 200min-'. There was no difference
between air- and CO-breathing animals. This HbCO level at
90min was 25%.
Blood oxygenation
The effect of acute and long-term exposure to various levels
of CO on HbCO and Pm as a function of breathing time is
shown in Figure 2. Thirty non-tumour-bearing mice were
'incubated' for each concentration at time zero. Blood sam-
ples were taken from three mice at each time point. For
practical and ethical reasons each mouse was measured only
once from each orbital sinus during the experiment. The
experiment was repeated once for each CO concentration.
One data point thus represents the mean and 95% confidence
interval of six different mice (and not the same mouse fol-
lowed consecutively). The results show that air-breathing
mice had an HbCO level of about 2%. After exposure to CO
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Figure 1 The ventilation rate determined by whole-body plethys-
mography in mice breathing either air (0) or CO 220 p.p.m. (0).
Points are mean and 95% confidence limits of six individual
measurements.52 C. GRAU et al.
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Figure 2 Blood oxygenation parameters in non-tumour-bearing
mice as a function of breathing time in CO 75 p.p.m. (0),
220 p.p.m (0), or 660 p.p.m. (V). a, Carboxyhaemoglobin
(HbCO). b, P50. Shaded areas are 95% confidence intervals of
the control value. Error bars are 95% confidence intervals.
the HbCO level rapidly increased, and reached dose-
dependent maximal values of approximately 10% (75 p.p.m.),
25% (220 p.p.m.) and 45% (660 p.p.m.) within the first 24 h.
The breathing of CO caused an increase in oxygen affinity
and a reduction in Pm within minutes. The P50 describes the
position of the oxygen dissociation curve, and for normal
air-breathing mice it was 38 mmHg (Figure 2b). The maximal
reduction in Pm with time was about 25% for CO 75 p.p.m.,
35% for 220 p.p.m. and 50% for 660 p.p.m. The strong
inverse relationship between the increase in HbCO and the
drop in Pso, the so-called Haldane effect, is shown in Figure
3a, in which the individual measurements of these parameters
are plotted against each other. There was no change in total
Hb as a function of HbCO level or breathing times up to 4
days. In fact, in another experiment the Hb content was
unchanged during a 3-week chronic CO-breathing period
(data not shown). Although the total Hb content remained
constant, the amount of Hb available for oxygen transporta-
tion was significantly reduced by CO breathing. The so-called
effective Hb, defined as total Hb - (HbCO + MetHb), is
shown as a function of HbCO level in Figure 3b. The MetHb
concentration was independent of all manipulations, and was
0.5% in this mouse strain.
One of the factors that strongly influences the P50 is the
2,3-DPG concentration. This parameter was obtained from
approximately half of the animals included in the blood gas
analysis. In contrast to what was expected, 2,3-DPG did not
increase as a response to the hypoxic stimulus from CO
breathing, but rather showed a slight decrease with longer
breathing time. This was true for both haemoglobin 2,3-DPG
(Figure 4) and whole-blood 2,3-DPG (data not shown).
There was no correlation between the CO concentrations and
the 2,3-DPG response. Similarly, there was no correlation
between the 2,3-DPG level and either HbCO, effective Hb or
Pm level.
In the tumour experiments a pretreatment breathing time
Carboxyhaemoglobin (%)
Figure 3 The correlation between blood carboxyhaemoglobin
(HbCO) level and a, P50 and b, total haemoglobin (0) or
effective haemoglobin (@). Points are individual measurements.
Line drawn by linear regression.
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Figure 4 The 2,3-DPG (as a percentage of HB content) as a
function of breathing time in CO 75 p.p.m. (0), 220 p.p.m. (@)
or 660 p.p.m. (V). Shaded areas are 95% confidence intervals of
the control value. Error bars are 95% confidence intervals.
of 45-60 min was used, by which time the blood oxygenation
parameters had stabilised at a dose-dependent level. The
HbCO or Pm values cited below refer to those values actually
measured in conjunction with each investigation or treatment
(from simultaneously gassed controls or in treated animals).
The values are thus not transposed from the blood gas
experiments.
Tumour bloodperfusion
Tumour blood perfusion was measured by the 86RbCl extrac-
tion technique (Figure 5). The mice were breathing CO for
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Figure 5 The effect of HbCO on tumour perfusion measured by
the 86RbCI technique. Line drawn by linear regression. Shaded
area represents perfusion in air-breathing controls (95%
confidence intervals).
Tumour oxygenation
The percentage of intratumoral microelectrode Po2
measurements with values less than or equal to 5 mmHg as a
function of the blood HbCO level is plotted in Figure 7a.
Mice were bireathing atmospheric air or CO for 45-60min
before and continuously during measurement. In air-
breathing mice 35% of measurements contained P02 values
less than or equal to 5 mmHg. This percentage rapidly in-
creased with increasing levels of HbCO. The value at CO
660 p.p.m. (81%) was not significantly different from that
obtained in clamped tumours (97%). The proportion of
clonogenic hypoxic cells (HF) was measured radiobiologically
using the clamped local tumour control technique. The
tumour control data obtained for mice breathing CO at 0,
75, 220 or 660 p.p.m. for 45min before and during local
radiotherapy were analysed together with the data for
clamped irradiation. The HF values obtained at different
HbCO levels are shown in Figure 7b, and listed in Table I.
The HF increased from 8% in air-breathing animals to 13%
(75 p.p.m.), 18% (220 p.p.m.) and 54% (660 p.p.m.). The
correlation was highly significant (r2= 0.97, P<0.05).
The correlation between HbCO and HF was significant
(r2 = 0.97, P<0.05) and similar to that observed for the P02.
45-60 min prior to 86RbCl injection. There was a significant
correlation between the HbCO level and the decrease in
tumour perfusion (r2=0.98, P<0.001). The reductions in
blood perfusion were 12% (NS), 45% (P<0.05) and 82%
(P<0.01) for average HbCO levels of 13%, 25% and 51%
respectively.
The combined effects of changes in effective Hb and
tumour blood perfusion on the oxygen supply to tumours are
illustrated in Figure 6. All values are expressed as percentage
of the values obtained in air-breathing controls. The per-
fusion effects are represented with the regression line from
Figure 5. The combined effect was calculated as the product
of the reduction in effective Hb and the estimated perfusion
reduction for animals at the actual HbCO level for each
mouse. It is seen that the negative impact of perfusion is
considerably greater than the reduction in effective Hb. When
combined, the amount of oxygen supplied to the tumour is
decreased down to 15% of the control value for the highest
HbCO level. Within the clinically relevant range, the reduc-
tion is about 30-40%.
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Figure 6 The effect of HbCO on tumour oxygen supply. All
values are relative to air-breathing controls. 0, total Hb; 0,
effective Hb; - - -, blood perfusion; *, oxygen supply, calculated
as the ratio of effective Hb to perfusion for air- and CO-
breathing animals.
Radiation response
The effect of CO breathing on the radiation-induced local
tumour control was studied with single dose and fractionated
irradiation. The TCDj0 data are summarized in Table I.
Figure 8a shows the significant correlation between the
HbCO level and the obtained TCD50 for single-dose irradia-
tion (r2 = 0.98, P<0.05). The responses of clamped tumours
are shown for comparison (shaded area). The negative effect
of HbCO on radiation response is plotted in a more clinically
relevant way in Figure 8b. This plot illustrates the loss of
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Figure 7 The effect of HbCO on a, percentage of intratumoral
P02 values less than or equal to 5 mmHg and b, radiobiological
hypoxic fraction of clonogenic cells, determined by direct analysis
of tumour control data for ambient and clamped tumours respec-
tively. Lines drawn by linear regression. Shaded areas represent
values from air-breathing controls (95% confidence intervals).
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Table I Effect of carbon monoxide breathing on the radiation-induced local tumour control and proportion of
radiobiologically hypoxic cells of a C3H mammary carcinoma in vivo
Rad. Breathing HbCO TCD50 Enhancement Hypoxic fraction
(n)a condition (%)b (Gy) ratioc (%)
1 Air 1-2 54 (52-56) - 8 (5-10)
1 CO 75 p.p.m. 7-9 57 (54-61) 0.94 (0.89-0.99)f 13 (7-18)
1 CO 220 p.p.m. 20-23 60 (56-63) 0.90 (0.85-0.95)f 18 (10-26)f
1 CO 660 p.p.m. 27-31 68 (64-71) 0.80 (0.76-0.84)f 54 (32-76)f
1 Clamped 1-2 71 (69-73) - 100 (68-132)f
5 Air 1-2 61 (59-63) - 1.5 (0.4-2.6)
5 CO 220 p.p.m. acuted 16-18 71 (64-79) 0.85 (0.78-0.93)f 3.0 (0.7-5.4)
5 CO 220 p.p.m. chron.e 10-14 67 (61-73) 0.91 (0.84-0.98)f 2.1 (0.5-3.6)
5 Clamped 1-2 113 (105- 120) - 100 (43-158)f
10 Air 1-2 87 (83-91) - 13 (6-20)
10 CO 220 p.p.m. 15 x 19 97 (94-101) 0.89 (0.85-0.94)f 26 (9-43)
10 Clamped 1 -2 119 (111-127) - 100 (23-177)f
15 Air 1-2 97 (92-103) - 40 (16-65)
15 CO 220p.p.m. 14-19 98 (92-105) 0.99 (0.93-1.06) 37 (14-60)
15 1-2 115 (105-126) - 100 (33-167)f
aRadiation given in n fractions in a total overall treatment time of 5 days. bCarboxyhaemoglobin (HbCO;range
of measured values pre and post-irradiation). cDefined as TCD" for air-breathing animals relative to CO-treating
animals. dExposed to CO only 45 min before the during treatment. cExposed chronically to a CO-containing
environment from tumour inoculation until the end of treatment. 'Exposed chronically to a CO-containing
environment from tumour inoculation until the end of treatment. fP<0.05 (compared with air-breathing control).
Numbers in brackets are 95% confidence limits.
a
0
L-
0
E
U
0
E
4-
cB0
cJ
0
J
/// // Air
100
80
60
40
20
0
0
1 fx
Id
0 @ 111
b t1
II /
II
100 O5fx (I09D9D9 9 S5fx
80
60
-o
40 0It
20
40 60 80 100 120
cooe* . lOfx A t//
ttI ozo/ ,~~~
15fx gS
r/
X/
60 80 100 120 140
-
0
0
E
Carboxyhaemoglobin (%)
Figure 8 The effect of HbCO on a, local tumour control
(TCD50) and b, tumour control rate at 60 Gy single-dose irradia-
tion. Shaded areas represent response in clamped or air-breathing
controls (95% confidence intervals). Error bars are 95%
confidence intervals.
tumour control for a fixed radiation dose of 60 Gy. The 80%
local tumour control rate in air-breathing mice declined to
about 50% within the clinically relevant HbCO range. The
correlation was significant (r2=0.99, P<0.01).
The influence of HbCO on local tumour control was fur-
ther investigated in a series of fractionated radiation
experiments. An overall treatment time of 5 days was used
Radiation dose (Gy)
Figure 9 Local tumour control for irradiation (one, five, ten or
15 fractions) in air-breathing (0), acute 220 p.p.m. CO-breathing
(O) or chronic l10 p.p.m. CO-breathing (V) mice. The dotted
lines indicate the response of clamped tumours. Error bars are
95% confidence intervals.
for all schedules, Figure 9 shows the local tumour control as
a function of the total radiation dose. For comparison, the
responses of clamped tumours are indicated with dashed
lines. There was a small, but highly significant increase in
TCD50 when the radiation was given in one, five or ten
fractions. This effect could not be found for 15 fractions, in
which case the two dose-response curves overlapped. The
calculated TCD5o and the corresponding enhancement ratios
are listed in Table I. For one, five and ten fractions, the
radiation ERs were 0.90, 0.85 and 0.89 respectively, which
was highly significant (P<0.005 for all values). Finally,
chronic smoking was simulated in a single experiment. Mice
maintained from tumour implantation until the end of the
five-fraction radiation treatment - a period of about 21 days
- in a 110 p.p.m. CO environment (HbCO 10-14%) had a
TCD50 that was not significantly different from that observed
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for mice that were only acutely exposed to 220 p.p.m. CO
during treatment (Figure 9, bottom left). The TCD50 was
significantly higher than for air-breathing controls (P<0.05).
The Hb levels of these chronic breathers were identical to
those of untreated controls (data not shown).
Discussion
This study has demonstrated that CO breathing causes a
significant decrease in tumour oxygen supply, which in turn
leads to severe tumour hypoxia and a reduction in radiation
response. It is established that the tumour oxygen supply is
impaired by three factors: reduction in effective Hb from
HbCO formation, decrease in P50 and reduction in tumour
blood perfusion. The combined effect results in at least
30-40% reduction in oxygen supply to the tumour within
the clinical HbCO range, and up to 85% for high CO
concentrations.
Our data show a dose-dependent reduction in P50 down to
about 50% of the normal value. Such increase in blood
oxygen affinity will decrease the oxygen utilisation depending
on the tissue P02 (Overgaard et al., 1992). It is not yet
possible to quantify exactly these changes in mouse blood in
the same way as has been done in humans (Overgaard et al.,
1992). However, an impression of the relative magnitude of
the Haldane effect can be obtained if the tissue Po2 is kept
constant. Then the effect of a reduction in P50 would be of
the same magnitude as the perfusion effect, i.e. up to 80%
reduction at the highest HbCO. A reliable estimate of the
tumour P02 can be obtained from the microelectrode
measurements. In the present experiments the mean P02
decreased linearly from 14 mmHg (air) to 3 mmHg (CO
660 p.p.m.). Such a drop with increasing tumour hypoxia will
facilitate oxygen release because of the increased concentra-
tion gradient, and thereby to some extent counteract the P"o
effect.
A reduction in P50 has also been observed for several
therapeutic agents. These agents include the substituted ben-
zaldehyde BW12C, which preferentially binds to oxyhaemo-
globin and thereby increases the affinity of Hb for oxygen
(Beddell et al., 1984; Horsman & Overgaard, 1992). Several
experimental studies have shown a significant increase in
tumour hypoxia and a reduction in radiation response when
mice are treated with BW12C (Adams et al., 1986; Adams,
1989; Honess et al., 1989). However, recent studies have
suggested that the observed radiation modification may be
more related to BW12C-induced blood flow reductions than
to the change in P50 (Honess et al., 1991, Horsman & Over-
gaard, 1992). A similar property was observed for CO
breathing, when perfusion reductions up to 80% were seen at
the highest CO concentration. Previous studies from our
laboratory with the C3H mouse mammary carcinoma and
the vasoactive agent hydralazine showed that at least a 50%
decrease in perfusion is required to see any effect on radia-
tion response and full radiobiological hypoxia is only seen
after a 90% reduction in perfusion (Horsman et al., 1989).
The Hb affinity for oxygen can also be decreased in order to
improve tumour radiosensitivity. This has been shown experi-
mentally with antilipidaemic agents (Hirst & Wood, 1987;
1989; Hirst et al., 1987) and a combination of inosine,
puruvate and phosphate (2,3-DPG precursors) (Siemann et
al., 1989). It is not known to what extent blood perfusion
changes are involved in the mechanisms of action of these
agents.
2,3-DPG is one of the most important allosteric factors
controlling the position of the oxygen dissociation curve
(Bunn & Forget, 1986). In conditions characterised by
hypoxia (chronic lung disease, cardiac insufficiency,
anaemia), the level of 2,3-DPG is increased, thereby making
the oxygenated Hb more readily available to the tissues by an
increase in the P50. This effect could not be seen in the
present study. A possible reason is that the hypoxic stimulus
from HbCO is not sufficient to trigger a sufficient
biochemical response.
The chronic effects of smoking have generally been
believed to include a compensatory polycythaemia. However,
the magnitude of such polycythaemia in persons without
chronic lung disease is very small. In a large study of more
than 4000 persons the Hb level in smokers was less than 3%
above that of non-smokers (Nordenberg et al., 1990), and in
head and neck cancer patients no increase in Hb as a func-
tion of HbCO level has been found (Overgaard et al., 1992).
In the present mouse material we found no increase in Hb
during the 3 weeks of chronic 'incubation' at 10% HbCO. So
it is unlikely that chronic CO breathing/smoking leads to any
significant adaptation, which is also shown by the data in
Figure 9. The present set-up with acute CO breathing
therefore seems to be a reasonable simulation of the clinical
situation.
The local tumour control studies showed that even within
the clinically relevant HbCO range the radiation. response
was significantly reduced for single-dose and fractionated
irradiation with five or ten fractions. Similar or greater
radioprotection has been found in the SCCVII tumour using
the in vivo excision assay (C. Grau, unpublished observa-
tions, 1993). Mice with a HbCO of 10-13% had isoeffect
ERs between 0.76 and 0.83 for one, four, eight or 12 frac-
tions within 4 days. In the KHT tumour, Siemann et al.
(1978) similarly found significantly increased tumour cell sur-
vival when tumours were given daily fractionation with 5 Gy
during either acute or chronic exposure to CO giving a 10%
HbCO level.
The only schedule in the present set-up where CO
breathing did not decrease the radiation response was when
15 fractions were delivered as three daily fractions. A possi-
ble explanation of this finding may be that reoxygenation in
such a hyperfractionated setting is not complete between
fractions, and the contribution of 'CO-induced hypoxia' is
therefore less important. There are some data to support this
hypothesis. Using the previously published local tumour con-
trol data for clamped tumours (Bentzen & Grau, 1991), it
was possible to calculate the 'effective' hypoxic fractions for
the different fractionation schedules similar to what was done
for the single-dose data. For five fractions (i.e. 24 h interval)
the effective hypoxic fraction was significantly lower than
that for untreated tumours (1.5% vs 8%), indicating that
reoxygenation between fractions was very efficient (Table I
and Figure 10). The hypoxic fraction was increased by a
factor of 2 by CO breathing. For twice-daily fractionation
(i.e. 6 and 18 h intervals) the hypoxic fraction was 13% in
aerobic tumours, indicating that reoxygenation was almost
complete. Again, CO breathing caused a doubling of the
hypoxic fraction. For three daily fractions (i.e. 6- 6- and 12 h
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Figure 10 The 'effective' hypoxic fraction during different frac-
tionation schedules in air-breathing (0) or CO-breathing (-)
mice. Error bars are 95% confidence intervals.56 C. GRAU et al.
intervals), however, the effective hypoxic fraction increased to
40%, possibly as a result of insufficient reoxygenation. In this
situation CO breathing did not further increase the hypoxic
fraction.
The clinical data on the influence of smoking on radiation
response are remarkably sparse. A recent prospective study
has shown that the survival of smokers undergoing
radiotherapy for head and neck cancer is significantly
reduced compared with non-smokers of the same clinical
stage (Browman et al., 1993). The 2-year disease-free survival
rate was 66% in non-smokers compared with 39% in the
patients who continued to smoke during treatment
(P = 0.005). The conclusion of the study was that patients
should be advised to stop smoking during therapy. Similar
suggestions have been made retrospectively in carcinoma of
the uterine cervix (Kucera et al., 1987), but in another study
in the same patient category smoking was found to be a
non-significant prognostic factor (Solberger & Sorbe, 1990).
Protection of the normal tissue by CO breathing may
influence the therapeutic importance of the present findings.
However, in a recent study (Browman et al., 1993), no
difference in the incidence and severity of stomatitis and skin
toxicity between smokers and abstainers was found. Apart
from these studies there exist (at least to our knowledge) no
good data on this topic.
In conclusion, the present data have shown that elevated
HbCO levels can lead to increased tumour hypoxia as a
result of changes in blood oxygenation and tumour blood
perfusion, and that the induced hypoxia has a significant
impact on the local tumour control after both single-dose
and fractionated irradiation.
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